NEW YORK (GenomeWeb) – Bruker announced this week that it has completed its previously announced acquisition of an 80 percent majority interest in Nehren, Germany-based Hain Lifescience. Hain is a provider of molecular diagnostics for the detection of microbial and viral pathogens, as well as for molecular antibiotic resistance testing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Vox explores a proposal to institute a lottery system to award grant funds.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.